Sign In
Buy ABT
$100.79
+0.200 (+0.199%)
At Close: Jul 23, 2026
Study at ADA's Scientific Sessions shows participants in Abbott's Healthy Food Rx program combined with health coaching had significant health improvements Abbott's Healthy Food Rx program is a Food i
Baron Discovery Fund Q1 2026: Who Moved The Needle
01:35am, Monday, 08'th Jun 2026
In the first quarter of 2026, Baron Discovery Fund declined 10.65% (Institutional Shares), trailing the Russell 2000 Growth Index by 7.84% due to significant underperformance in the software sector. A
New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis
10:00am, Saturday, 06'th Jun 2026
New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis PR Newswire A
New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis
09:00am, Saturday, 06'th Jun 2026
Diabetic ketoacidosis (DKA) can develop quickly and is not always easy to detect early Ketone monitoring is not yet routine in diabetes care, which may contribute to missed warning signs of DKA and de
Abbott Labs must face lawsuit over PediaSure children's growth claims
03:46pm, Thursday, 04'th Jun 2026
Abbott Laboratories must defend against a proposed class-action lawsuit claiming it misled consumers into believing its PediaSure Grow & Gain nutrition drinks were "clinically proven" to help child
Abbott Addresses a Major Diabetes Care Gap With Tech Innovation
11:02am, Thursday, 04'th Jun 2026
ABT wins the CE Mark for Libre Duo sensors that track glucose and ketones every minute, aiming to spot DKA risks earlier and reduce routine testing.
ABT DCF Analysis: Intrinsic Value $93 vs Price $88
07:04am, Tuesday, 02'nd Jun 2026
On June 02, 2026, we take a closer look at the DCF analysis for Abbott Laboratories (ABT). The stock has experienced notable price performance, with a year-to-d
3 Beaten-Down Stocks to Buy and Hold Forever
04:15am, Tuesday, 02'nd Jun 2026
Don't wait too long to buy the dip on these stocks.
Abbott's CE Mark Win for Libre Duo Systems May Lift Its Stock
10:56am, Monday, 01'st Jun 2026
ABT wins CE Mark for Libre Duo systems, the first dual glucose-ketone sensors, enabling real-time monitoring as European rollout begins later this year.
BSX vs. ABT: Which Medical Stock Has More Upside Potential?
10:16am, Friday, 29'th May 2026
Boston Scientific and Abbott both posted solid quarterly growth, but analysts see stronger upside for Boston Scientific despite mounting operational pressures.
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
10:01am, Friday, 29'th May 2026
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?
10:31am, Thursday, 28'th May 2026
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know
06:51pm, Wednesday, 27'th May 2026
Abbott (ABT) concluded the recent trading session at $85.68, signifying a -1.14% move from its prior day's close.
How Abbott's Diagnostics Unit Is Shaping Up Through the Rest of 2026
09:53am, Wednesday, 27'th May 2026
ABT's Diagnostics unit witnesses mixed Q1 results as Core Lab growth offsets China weakness and softer respiratory testing demand.
Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes
09:00am, Wednesday, 27'th May 2026
First-of-its-kind biowearables combine continuous glucose and ketone monitoring in a single sensor to support both daily diabetes management and help detect rising ketone levels that can lead to diabe
